Stem Cell Therapy For COVID-19,Cure Levels Reach 8 To 10 Days

Zhang Xinmin, director of the Biological Center of the Ministry of Science and Technology, said on the 17th that since the outbreak of the COVID-19 epidemic, the scientific research group launched the emergency research project for stem cell therapy for the clinical research of COVID-19. The results show that stem cell therapy for COVID-19 patients is safe and effective, and can make breathing difficulties in severe and critically ill patients relieved or stopped aggravating quickly. The clinical manifestations, respiratory function, and imaging examinations have all improved. Generally, cure levels can be reached in 8-10 days. In addition, the role of stem cells in blocking pulmonary fibrosis and promoting lung injury repair has shown that it has unique advantages in preventing pulmonary fibrosis and improving the long-term prognosis of patients.